ACI submits tox data to FSA

The Association for the Cannabinoid Industry (ACI) submitted a complete toxicological package to the Food Standards Agency (FSA) on Friday, 4 November 2022, to support members’ novel food applications. These applications account for 33% of the applications made to the FSA, and align to approximately half of the products identified on the public list. Currently […]
Professor Christopher Hodges of the Hodges Review is appointed Chair of the Regulatory Horizons Council

Professor Christopher Hodges OBE, who recently completed a strategic review of the UK’s legal cannabinoid industry for the Center of Medicinal Cannabis and the Association for the Cannabinoid Industry, has been appointed Chair of the Regulatory Horizons Council by the Business Secretary. The Oxford professor will now take up the role for a term of […]
The Hodges Review gauges public support for the UK’s ‘accidental’ cannabis sector

The main objective of the Hodges Review was to examine the current cannabis sector landscape and outline how best to support the safe and responsible growth – economic and social – of a sizeable and dynamic legal sector that is already established in the UK. Despite the growth potential and dedication within the industry, the report […]
EFSA reveals several areas of concern in novel food applications

The European Food Safety Authority (EFSA) has found several key areas of concern in novel food submissions it has received for CBD. Among the areas of primary concern are missing information on applications and data gaps, which would support the evaluation of safety profiles, according to information shared during an EFSA-led webinar on 29 June. […]
CBD in food: 12,000 products now pending authorisation as FSA releases final list

The Food Standards Agency has updated the public list of CBD products, adding an additional 6,000 products. This is the complete list of ingestible CBD products currently allowed to remain on the market, which have been linked to a credible novel foods application. These are the only ingestible CBD products which can be sold […]
Call for government to turbocharge UK cannabinoid innovation, as Minister for Science addresses industry leaders

A groundbreaking new report published today sets out 20 key recommendations which, upon implementation, would set the UK on a path to become the global leader in cannabinoid innovation. From Containment to Nurturing: How the UK can become a world leader in cannabinoid innovation was commissioned by the Centre for Medicinal Cannabis (CMC) and the […]
EFSA suspends novel food applications due to ‘data gaps and uncertainties’ 

The European Food Safety Authority (EFSA) has ‘stopped the clock’ on 19 novel food applications for CBD, pending new data. The EU authority says its scientists cannot currently establish the safety of CBD as a novel food due to data gaps and uncertainties about potential hazards related to CBD intake. The news follows the submission […]
Celebrating 3 years of Naturecan

Naturecan, the UK CBD brand born out of Stockport, is celebrating three years in business. We caught up with some of the team to look back on the highlights of the company’s journey so far. It all started with a lightbulb moment in 2018, when Naturecan co-founder Paul Finnegan had an idea to create CBD […]
Back on track: Swiss ingredients manufacturer Linnea reinstated on FSA’s CBD list

Linnea, the expert manufacturer of botanical extracts for the pharmaceutical industry, has had its novel foods application reinstated by the Food Standards Agency, following its removal from the list earlier this year. Cannabinoid Insight understands the company was originally told its application had been validated, only for the FSA to later rule Linnea out due […]
FSA adds further 2,500 CBD products to the public list

The Food Standards Agency (FSA) has added a further 2,500 CBD products to the register of products allowed to remain on the market for the time being. This brings the total number of ingestible CBD products permitted for sale in England and Wales to 5,946 pending full market authorisation, while 35 have been removed. The […]